Antipsychotics tied to increased odds of gynecomastia

03/18/2014 | Medscape (free registration)

An analysis of data from a large health plan database in the U.S. found that older men who took second-generation antipsychotic drugs risperidone or paliperidone were 69% more likely to develop gynecomastia than nonusers. The findings were presented at the annual meeting of the American Association for Geriatric Psychiatry.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC